PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company engaged in the discovery & development of RNA-based therapeutics for the treatment of severe genetic disorders.

$6.40  +0.39 (6.49%)
As of 04/14/2021 12:39:27 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  The Netherlands
Country of incorporation:  The Netherlands
IPO date:  09/18/2014
Outstanding shares:  50,204,810
Average volume:  9,602,482
Market cap:   $301,730,908
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    N71542109
ISIN:        NL0010872495
Sedol:      BQRX1W2

---

Valuation   (See tab for details)

---

PE ratio:   -22.89
PB ratio:   5.29
PS ratio:   1,009.30
Return on equity:   -81.56%
Net income %:   -18,551.79%